SCHEMBL16115993

SCHEMBL16115993

COC(=O)c1cc(-c2ccncc2)cn1C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 2/20 0.68
CDK8 P49336 2/20 0.68
NR4A2 P43354 3/20 0.56
AURKA O14965 1/20 0.49
TTK P33981 1/20 0.49
AURKB Q96GD4 1/20 0.49
INCENP Q9NQS7 1/20 0.49
CYP46A1 Q9Y6A2 1/20 0.46
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 2/20 0.43
AXL P30530 1/20 0.43
PKM P14618 1/20 0.42
KDM4E B2RXH2 2/20 0.42
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1254366 0.84 NR4A2 (0.54) CCNCCDK8NR4A2CYP1A2CYP2C19
SCHEMBL31454230 0.84 CCNC (0.62) CCNCCDK8NR4A2AURKATTK
SCHEMBL12582220 0.83 NR4A2 (0.46) CCNCCDK8NR4A2CYP1A2CYP2C19
SCHEMBL31454214 0.82 NR4A2 (0.59) CCNCCDK8NR4A2CYP2C19ALDH1A1
SCHEMBL16115664 0.82 CCNC (0.73) CCNCCDK8NR4A2AURKATTK
SCHEMBL13987886 0.81 CCNC (0.46) CCNCCDK8NR4A2CYP1A2CYP2C19
SCHEMBL2025582 0.81 CCNC (0.48) CCNCCDK8NR4A2CYP1A2CYP2C19
SCHEMBL16115074 0.81 CCNC (1.00) CCNCCDK8NR4A2AURKATTK
SCHEMBL16691882 0.79 CYP1A2 (0.44) CCNCCDK8NR4A2CYP1A2CYP2C19
SCHEMBL25197344 0.78 CCNC (0.41) CCNCCDK8NR4A2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119365460-A Compounds that interact with Ras superfamily proteins for the treatment of cancer, inflammatory diseases, RAS diseases, and fibrotic diseases 尚医治疗有限责任公司 2025-01-24 CN disclosed
WO-2014154723-A1 NOVEL PYRROLE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-10-02 WO disclosed
WO-2014154723-A1 NOVEL PYRROLE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-10-02 WO disclosed